Bacitracin Ophthalmic Ointment Shortage: Supply Issues Reported Due to Manufacturing Discontinuation

What’s in Shortage

Bacitracin Ophthalmic Ointment (Brand Name: BACITRACIN) is currently listed in a shortage status. This medication is classified under the therapeutic categories of Anti-Infective and Ophthalmology and is administered as an ophthalmic ointment.

Which Manufacturers Are Affected

The following manufacturer is currently impacted:

• Padagis US LLC
  • Status: Unavailable
  • Presentation: Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)
  • Notes: The shortage for this product is estimated to last for approximately 20 months.
  • Contact Information: 866-634-9120

Why There’s a Shortage

The current shortage is attributed to the discontinuation of the manufacture of the drug.

What Patients Should Do

Patients who rely on Bacitracin Ophthalmic Ointment should take the following steps:

1. Consult Your Healthcare Provider: Speak with your doctor or ophthalmologist to discuss the shortage and determine the best course of action for your specific medical needs.
2. Talk to Your Pharmacist: Your pharmacist can provide information on current local availability or help coordinate with your physician regarding alternatives.
3. Contact the Manufacturer: For specific questions regarding supply timelines, you may contact Padagis US LLC at the number provided above.

Disclaimer: This article is for informational purposes only. Patients should always consult their healthcare provider for medical advice, diagnosis, or treatment options regarding medication changes.

Source

Information provided by the FDA Drug Shortage Database.

• Initial Posting Date: 03/03/2025
• Last Updated: 02/04/2026